The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNuformix Regulatory News (NFX)

Share Price Information for Nuformix (NFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.19
Bid: 0.18
Ask: 0.20
Change: -0.01 (-5.00%)
Spread: 0.02 (11.111%)
Open: 0.20
High: 0.00
Low: 0.00
Prev. Close: 0.20
NFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

20 Aug 2020 11:33

RNS Number : 7285W
Nuformix PLC
20 August 2020
 

Nuformix plc

("Nuformix" or the "Group")

 

 

Result of Annual General Meeting held on 20 August 2020

 

 

Cambridge, UK - 20 August 2020: Nuformix plc (LSE:NFX) announces that all resolutions proposed at its Annual General Meeting held today were duly passed on a poll, the results of which are set out below:

 

 

Votes For

% of Votes Cast

Votes Against

% of Votes Cast

Votes Withheld1

1

To receive the annual report and accounts for the year ended 31 March 2020

160,439,143

97.06

4,859,946

2.94

3,215,648

2

To approve the remuneration report contained within the Annual Report for the year ended 31 March 2020

160,409,517

97.05

4,871,780

2.95

3,233,440

3

To re-appoint Jo Holland as a director

160,421,351

97.06

4,859,946

2.94

3,233,440

4

To re-appoint Christopher Blackwell as a director

139,069,040

82.53

29,447,905

17.47

17,792

5

To appoint Karl Keegan as a director

139,057,206

82.52

29,459,739

17.48

17,792

6

To re-appoint Haysmacintyre as auditor of the Company

160,439,143

97.06

4,859,946

2.94

3,215,648

7

To authorise the directors to determine the remuneration of the auditor

160,421,351

97.05

4,877,738

2.95

3,215,648

8

To authorise the directors to allot shares

139,069,040

84.13

26,230,049

15.87

3,215,648

9

Authority to disapply pre-emption without restriction as to use (Special Resolution)

139,069,040

84.13

26,230,049

15.87

3,215,648

10

Authority to disapply pre-emption for acquisitions or specified capital investments (Special Resolution)

148,518,064

84.99

26,230,049

15.01

3,215,648

11

To authorise the Company to purchase its own shares (Special Resolution)

169,876,333

97.21

4,871,780

2.79

3,215,648

12

To authorise the Company to call a general meeting on not less than 14 clear days' notice (Special Resolution)

148,506,230

84.98

26,241,883

15.02

3,215,648

 

 

1 A vote withheld is not a vote under English law and is therefore not included in the calculation of votes for and against a resolution.

In accordance with Listing Rule 9.6.2, a copy of all resolutions passed as special business will shortly be available for inspection at the National Storage Mechanism document viewing facility at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

Enquiries:

 

Nuformix plc

Roger Jones, Company Secretary

Fleur Wood, Investor Relations

Email: fleur.wood@nuformix.com

 

 

+44 (0)1223 627222

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGBBLFLBVLXBBF
Date   Source Headline
19th Mar 20242:39 pmRNSResult of AGM
1st Mar 20247:00 amRNSSubscription to raise £150,000
15th Jan 202411:30 amRNSPosting of Annual Report and Notice of AGM
3rd Jan 20247:00 amRNSResults for the period ended 30 September 2023
18th Dec 20237:00 amRNSNXP001 Update
23rd Oct 20237:00 amRNSNotice of Allowance of NXP002 Patent in Japan
18th Sep 20237:00 amRNSNXP001 Update
24th Aug 20231:22 pmRNSResult of Annual General Meeting
31st Jul 20232:00 pmRNSNotice of AGM
26th Jul 20232:55 pmRNSHolding(s) in Company
2nd Jun 20237:00 amRNSInvestor Online Q&A
25th May 20237:00 amRNSChange of Auditor
22nd May 20237:00 amRNSUnaudited Interim Report
18th May 20237:00 amRNSNXP002 Inflammation and Duration of Action Update
26th Apr 202310:55 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSSubscription to raise £70,000 & issue of Warrants
27th Mar 20237:00 amRNSNXP002 Update
13th Mar 20237:00 amRNSChange of Accounting Reference Date
15th Feb 20237:00 amRNSNXP002 Update
3rd Jan 20231:37 pmRNSHolding(s) in Company
20th Dec 20221:02 pmEQSNuformix hoping to 'initiate discussions with major pharma' in 2023
20th Dec 20227:00 amRNSNXP004 Update
13th Dec 20227:00 amRNSHalf-year Report
5th Dec 20227:00 amRNSResignation of Auditor
16th Nov 20228:50 amRNSHolding(s) in Company
4th Nov 20227:00 amRNSInvestor Webinar
23rd Sep 20227:00 amRNSNXP002 Update
23rd Sep 20227:00 amRNSNXP002 Update
25th Aug 20222:39 pmRNSResult of AGM
19th Aug 20228:57 amRNSHolding(s) in Company
10th Aug 20227:00 amRNSNXP002 Completion of Tolerability Studies
1st Aug 202212:13 pmRNSPosting of Annual Report and Notice of AGM
28th Jul 20227:01 amRNSBoard Changes
28th Jul 20227:00 amRNSAnnual Results for the year ended 31 March 2022
5th Jul 20227:00 amRNSNXP002 data to be presented at 2022 ERS Congress
29th Jun 20227:00 amRNSNXP004 Update
27th Jun 20227:00 amRNSNXP002 Update
20th Jun 20227:00 amRNSHolding(s) in Company
31st May 20227:00 amRNSDirectorate Change
30th May 20227:00 amRNSCorporate Update
12th Apr 20227:00 amRNSSecond tranche of Lanstead subscription shares
11th Apr 20223:54 pmRNSHolding(s) in Company
8th Apr 202211:21 amRNSHolding(s) in Company
7th Apr 20223:44 pmRNSHolding(s) in Company
5th Apr 20226:07 pmRNSHolding(s) in Company
28th Mar 20227:00 amRNSNXP004 Patent
2nd Mar 20227:00 amRNSAppointment of Dr Dan Gooding as Consultant
1st Mar 20227:00 amRNSChange of Auditor
14th Feb 20224:37 pmRNSHolding(s) in Company
8th Feb 20227:00 amRNSOxilio NXP-001 formulation development contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.